Erica N. Browne

ORCID: 0000-0003-2069-6589
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • Adolescent Sexual and Reproductive Health
  • HIV, Drug Use, Sexual Risk
  • Ocular Diseases and Behçet’s Syndrome
  • Opioid Use Disorder Treatment
  • Vaccine Coverage and Hesitancy
  • Retinal and Optic Conditions
  • Food Security and Health in Diverse Populations
  • Global Maternal and Child Health
  • Homelessness and Social Issues
  • Retinal Diseases and Treatments
  • Sex work and related issues
  • Intimate Partner and Family Violence
  • Forensic Toxicology and Drug Analysis
  • Substance Abuse Treatment and Outcomes
  • Criminal Justice and Corrections Analysis
  • Reproductive Health and Contraception
  • COVID-19 epidemiological studies
  • Health disparities and outcomes
  • Health Policy Implementation Science
  • HIV/AIDS Impact and Responses
  • Community Health and Development
  • Influenza Virus Research Studies
  • Migration, Health and Trauma
  • Poxvirus research and outbreaks

RTI International
2018-2025

Community Impact
2023

University of California, Berkeley
2023

University of California, San Francisco
2014-2019

San Francisco Foundation
2014-2019

Public Health Department
2018

University of North Carolina at Chapel Hill
2017

Kwame Nkrumah University of Science and Technology
2007

Abstract Introduction Preventing HIV and unintended pregnancies are key global health priorities. To inform product rollout to understand attributes of future multipurpose prevention technologies ( MPT ) associated with preference use, we evaluated three placebo delivery forms: daily oral tablets, a monthly vaginal ring, two intramuscular injections in TRIO , five‐month study among young Kenyan South African women. Methods ‐negative, sexually active, non‐pregnant women aged 18 30 were...

10.1002/jia2.25094 article EN cc-by Journal of the International AIDS Society 2018-03-01

Integrating end-user perspectives into the design of new biomedical HIV prevention products is recognized as vital to informing product development pipeline.Kisumu, Kenya; and Soshanguve, South Africa.We conducted a discrete choice experiment survey with 536 women aged 18-30 years assess preferences for hypothetical characterized by attributes efficacy, pregnancy prevention, delivery form, dosing frequency, side effects. Participants included product-experienced from Tablet, Ring, Injection...

10.1097/qai.0000000000001945 article EN cc-by JAIDS Journal of Acquired Immune Deficiency Syndromes 2019-01-14

Abstract Introduction Existing biomedical HIV prevention options, though highly effective, present substantial adherence challenges. End‐user input on early‐stage design of new approaches is critical to yielding products that achieve high uptake and adherence. The iPrevent Study examined youths’ preferences for key attributes long‐acting Pre‐Exposure Prophylaxis (PrEP), with a focus characteristics pertinent product delivery alongside modifiable attributes. Methods A discrete choice...

10.1002/jia2.25528 article EN cc-by Journal of the International AIDS Society 2020-06-01

Adherence to HIV prevention methods is a challenge, particularly for young women in Sub-Saharan Africa. End-user research during product development can inform modifiable factors increase future uptake and adherence.Preferences four vaginally inserted placebo were assessed among Zimbabwean South African using crossover clinical design. For each of months 1 4, participants asked use pre-coitally film, insert (vaginal tablet) gel once/week month, monthly ring randomly assigned sequence....

10.1002/jia2.25283 article EN cc-by Journal of the International AIDS Society 2019-05-01

Social media has been recognized as a promising tool for delivering health interventions and facilitating study recruitment. However, research is needed to understand how social might be used enhance the experiences of adolescent participants in ongoing studies. In prospective cohort addressing structural influences on trajectories among 599 adolescents California agricultural community, we evaluated effectiveness engagement with human-centered, Instagram-based outreach campaign, focus...

10.1177/2055207620904548 article EN cc-by-nc-nd Digital Health 2020-01-01

With the increased use of data from electronic medical records for research, it is important to validate International Classification Diseases, Ninth Revision (ICD-9) codes their respective diagnoses.To assess accuracy using ICD-9 identify ocular inflammatory diseases.Retrospective secondary database analysis. The setting was Kaiser Permanente Hawaii, an integrated managed care consortium that serves approximately 15% general Hawaiian population. Participants were patients with diagnosis...

10.1001/jamaophthalmol.2016.2166 article EN JAMA Ophthalmology 2016-07-07

Abstract As new female-initiated HIV prevention products enter development, it is crucial to incorporate women’s preferences ensure will be desired, accepted, and used. A discrete-choice experiment was designed assess the relative importance of six attributes stated choice a vaginally delivered product. Sexually active women in South Africa Zimbabwe aged 18–30 were recruited from two samples: product-experienced randomized trial four vaginal placebo forms product-naïve community members. In...

10.1007/s10461-019-02715-1 article EN cc-by AIDS and Behavior 2019-11-06

Abstract We evaluated the acceptability of 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 end product use (median 24 months, IQR 15–30). Monthly returned rings classified nonadherent if release rate was ≤ 0.9 mg/month. Associations between nonadherence estimated Poisson regression models with robust standard errors. At (N = 2334), 88%...

10.1007/s10461-021-03205-z article EN cc-by AIDS and Behavior 2021-03-13

HIV and other medical complications of drug use, including overdose, are rising among people who inject drugs in the United States (US). Risk mortality increase with injection behaviors such as syringe sharing, rushing injections, injecting isolated places. Studies suggest safe consumption sites (SCS) reduce high-risk by offering sterile syringes a safe, supervised space to consume drugs, although this has yet be evaluated US.An unsanctioned SCS an undisclosed US location.From 2018 2019, we...

10.1097/qai.0000000000002849 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2021-11-01

Hazardous drinking is an important contributing factor to intimate partner violence (IPV) occurrence. However, only a limited number of community-based alcohol reduction interventions have been tested in low- and middle-income countries (LMICs) for their efficacy reducing IPV. This pilot intervention study 1-month combined behavioral economics cognitive therapy reduce hazardous use IPV Bengaluru, India. Sixty couples were randomized one three arms test the effect incentives-only incentives...

10.1177/0886260519898431 article EN Journal of Interpersonal Violence 2020-01-20

Abstract Background The United States (US) continues to face decades-long increases in opioid overdose fatalities. As an reversal medication, naloxone can dramatically reduce mortality rates when distributed people likely experience or witness and packaged with education on its use, known as distribution (OEND). Syringe services programs (SSPs) are ideal venues for OEND staff who culturally competent providing at risk of experiencing observing overdose. We carried out a randomized controlled...

10.1186/s13012-024-01354-y article EN cc-by Implementation Science 2024-02-28
Coming Soon ...